BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 31557902)

  • 41. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EMT and CSC-like properties mediated by the IKKβ/IκBα/RelA signal pathway via the transcriptional regulator, Snail, are involved in the arsenite-induced neoplastic transformation of human keratinocytes.
    Jiang R; Li Y; Xu Y; Zhou Y; Pang Y; Shen L; Zhao Y; Zhang J; Zhou J; Wang X; Liu Q
    Arch Toxicol; 2013 Jun; 87(6):991-1000. PubMed ID: 23069812
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autocrine Fibronectin Inhibits Breast Cancer Metastasis.
    Shinde A; Libring S; Alpsoy A; Abdullah A; Schaber JA; Solorio L; Wendt MK
    Mol Cancer Res; 2018 Oct; 16(10):1579-1589. PubMed ID: 29934326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sub-circuits of a gene regulatory network control a developmental epithelial-mesenchymal transition.
    Saunders LR; McClay DR
    Development; 2014 Apr; 141(7):1503-13. PubMed ID: 24598159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links.
    Scheel C; Weinberg RA
    Semin Cancer Biol; 2012 Oct; 22(5-6):396-403. PubMed ID: 22554795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway.
    Zhou M; Hou Y; Yang G; Zhang H; Tu G; Du YE; Wen S; Xu L; Tang X; Tang S; Yang L; Cui X; Liu M
    Stem Cells; 2016 Jan; 34(1):55-66. PubMed ID: 26418365
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EMT as the ultimate survival mechanism of cancer cells.
    Tiwari N; Gheldof A; Tatari M; Christofori G
    Semin Cancer Biol; 2012 Jun; 22(3):194-207. PubMed ID: 22406545
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells.
    Ke XS; Qu Y; Cheng Y; Li WC; Rotter V; Øyan AM; Kalland KH
    BMC Genomics; 2010 Nov; 11():669. PubMed ID: 21108828
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SNAI1-mediated epithelial-mesenchymal transition confers chemoresistance and cellular plasticity by regulating genes involved in cell death and stem cell maintenance.
    Lim S; Becker A; Zimmer A; Lu J; Buettner R; Kirfel J
    PLoS One; 2013; 8(6):e66558. PubMed ID: 23799116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiation-Induced Pulmonary Epithelial-Mesenchymal Transition: A Review on Targeting Molecular Pathways and Mediators.
    Nagaraja SS; Nagarajan D
    Curr Drug Targets; 2018; 19(10):1191-1204. PubMed ID: 29412104
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enrichment of cancer stem-like cells by the induction of epithelial-mesenchymal transition using lentiviral vector carrying E-cadherin shRNA in HT29 cell line.
    Saltanatpour Z; Johari B; Alizadeh A; Lotfinia M; Majidzadeh-A K; Nikbin B; Kadivar M
    J Cell Physiol; 2019 Dec; 234(12):22935-22946. PubMed ID: 31111504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA control of epithelial-mesenchymal transition in cancer stem cells.
    Hao J; Zhang Y; Deng M; Ye R; Zhao S; Wang Y; Li J; Zhao Z
    Int J Cancer; 2014 Sep; 135(5):1019-27. PubMed ID: 24500893
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of hypoxia on the acquisition of epithelial-mesenchymal transition and cancer stemness: a possible link to epigenetic regulation.
    Yeo CD; Kang N; Choi SY; Kim BN; Park CK; Kim JW; Kim YK; Kim SJ
    Korean J Intern Med; 2017 Jul; 32(4):589-599. PubMed ID: 28704917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial mesenchymal transition Transcription Factor (TF): The structure, function and microRNA feedback loop.
    Alidadiani N; Ghaderi S; Dilaver N; Bakhshamin S; Bayat M
    Gene; 2018 Oct; 674():115-120. PubMed ID: 29936265
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Roles of genetic and microenvironmental factors in cancer epithelial-to-mesenchymal transition and therapeutic implication.
    Yang L; Shang Z; Long S; Wang N; Shan G; Zhang R
    Exp Cell Res; 2018 Sep; 370(2):190-197. PubMed ID: 30075173
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multifaceted Roles of DNA Methylation in Neoplastic Transformation, from Tumor Suppressors to EMT and Metastasis.
    Casalino L; Verde P
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
    Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
    BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.